Effort on the design of a next-generation exoskeleton was begun by the vision of Dr. Siamak Arzanpour and Dr. Edward Park in 2014 to create a breakthrough in current exoskeleton technology that empowers individuals with motion disabilities to walk freely, naturally, and independently. They first met each other in 2001, as graduate students working in the same lab at the University of Toronto. A decade later, as professors at Simon Fraser University in British Columbia, Canada, they brought together a highly talented group of students, end-users, therapists, and organizations to bring the dream to reality. In 2016, they co-founded Human in Motion Robotics Inc. and took the technology out of their research lab to improve the quality of life of millions of people around the world.
“Our XoMotion exoskeleton will allow me and millions of others living with motion disability to
walk back into their lives with pride and independence.”
- Chloё Angus T10 Paraplegic and HMR Lived Experience Lead
※ For the complete video please visit : https://www.youtube.com/watch?v=5Z8iTTOmwqE
HMR was incorporated after a successful demonstration of transferring the 3D motion of a novel compact robotic joint to articulate complex 3D human joint motions in Dr. Arzanpour and Dr. Park’s research lab at Simon Fraser University.
HMR built its Alpha prototype (“Arnie”) to investigate the feasibility of the new exoskeleton concept in real-life application.
HMR fabricated its Beta I prototype (“Eli”), and four years after her injury, Chloe walked again independently by wearing it.
HMR developed its functional self-balancing prototype, Beta II (“Art”), which supported all the complex maneuvers with human-like gaits.
Beta II was tested by a diverse group of end users with various levels of injuries.
HMR completed its investigational unit, XoMotion-I (“Midnight Angel”), and had its first sales.
XoMotion-I has been delivered to Toronto Rehab (the largest rehab center in Canada) for pilot clinical testing.
HMR will complete the development of its rehab product, XoMotion-R, and receive market clearance to start selling to clinics.
Be tuned for the announcement of HMR’s personal use product, XoMotion-P. We are almost there.